Criminals target sensitive data left unencrypted after digital transformation initiatives

Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors.

The funds will be invested to continue building Recursion's AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology.

ALTEN Calsoft Labs launches blockchain clinical trial platform in partnership with clinical research organisation Clinlogix

The social network for cancer will use the funds to expand its service and enter new markets through its patient engagement platform

AI is being deployed in the NHS to improve healthcare delivery across a broad range of activities

Cala Health, which develops bioelectrical therapies for chronic diseases, has closed a $50 million Series C financing round

Owlstone Medical enters collaboration agreement with Actelion to develop breath-based diagnostic test for pulmonary hypertension.

There isn't any aspect of healthcare that isn't being transformed by technology. The health-related technologies on display reflected the work that is being done to prevent illness, to deliver more effective treatments, and to reduce the growing cost of healthcare.

MedCrypt, a medical device cybersecurity software provider, has closed a Series A round of $5.3 million, led by Section 32, with participation from Eniac Ventures and Y Combinator. The funds will be used for sales and marketing, and for product development.

Statistics published today in the UK by the Department of Health, the Office of Life Sciences and the Department for Business, reveal a mixed picture with an overall modest increase in life sciences economic activity in the ten years from 2009 to 2018.